Oncology & Cancer
Lipiodol: From intrusion until exile from the tumor microenvironment
An editorial paper has been published in Oncoscience titled, "Lipiodol: from intrusion until exile from the tumor microenvironment."
Jan 8, 2024
0
0
Carcinoma
Oncology & Cancer
Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) are used to treat a variety of different cancers. ICIs are antibodies that sensitize the body's own immune system to detect and destroy tumors. However, ICIs are not effective in all patients, ...
Jan 3, 2024
0
50
Oncology & Cancer
AI offers promise for earlier and more accurate hepatocellular carcinoma diagnosis
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. It is a major global health concern with rising rates, particularly in North Africa and East Asia. Although potentially curable in the early stages, ...
Dec 29, 2023
0
4
Oncology & Cancer
Mailed orders found to double liver cancer screening rates
Liver cancer screening among patients with cirrhosis almost doubled when they were mailed a signed order from their specialist, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. ...
Dec 22, 2023
0
0
Genetics
Acetaldehyde dehydrogenases in liver zonation and liver cancer
A study, published in the journal Gene Expression and led by Brady Jin-Smith from the Department of Pathology at Tulane University, focuses on ALDHs, a group of key enzymes that catalyze the irreversible oxidation of various ...
Dec 15, 2023
0
0
Oncology & Cancer
Video: Treating liver cancer
Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver cancer in the U.S. this year, and about 29,000 will die from the disease, according ...
Dec 13, 2023
0
0
Oncology & Cancer
Benign breast disease linked to increased risk for breast cancer
The overall risk for breast cancer (BC) is increased for women diagnosed with benign breast disease (BBD) in the percutaneous biopsy era compared with the general population, according to a study published online Dec. 13 ...
Dec 13, 2023
0
0
Immunology
Could a high-fiber diet improve cancer immunotherapy performance?
It's no secret that a high-fiber diet is good for you—just ask Google. Lots of research suggests that eating a high-fiber diet can lower your risk for certain cancers, but less is known about whether fiber can also help ...
Dec 13, 2023
0
0
Oncology & Cancer
Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers
A new study, published online ahead of print in Journal for ImmunoTherapy of Cancer on December 6, has identified a novel biomarker for ICIs in human cancers.
Dec 13, 2023
0
12
Oncology & Cancer
Skipping adjuvant radiotherapy may not impact risk of recurrence or progression in patients with low-risk DCIS
Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received adjuvant radiotherapy, according ...
Dec 8, 2023
0
0
